slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 23,791-23,820
Pages 1,371
Rows per page 30
Component
23,791-23,820 of 41,127
07
The slide uses a color-coded map of Michigan to segment the bank's operations into five distinct regions.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corporation
Conference presentation Investor relations Beat · Need1 hit
02
jetBlue | Results Presentation Deck | 29 slidesjetBlue | Results Presentation Deck | 29 slides · JetBlue
Conference presentation Investor relations 1 hit
04
The slide uses a 2x2 grid layout to present financial metrics and forward-looking assumptions.jetBlue | Results Presentation Deck | 29 slides · JetBlue
Conference presentation Investor relations 1 hit
10
The chart compares actual revenue performance against 2019 levels, with a specific focus on the sequential improvement trend.jetBlue | Results Presentation Deck | 29 slides · JetBlue
Conference presentation Investor relations 1 hit
18
The slide uses stacked bar charts to show the composition of debt payments and interest savings.jetBlue | Results Presentation Deck | 29 slides · JetBlue
Conference presentation Investor relations 1 hit
19
The slide includes a disclaimer that these are planning assumptions as of July 27, 2021, and do not constitute formal guidance.jetBlue | Results Presentation Deck | 29 slides · JetBlue
Conference presentation Investor relations 1 hit
21
Includes both GAAP and non-GAAP financial measures.jetBlue | Results Presentation Deck | 29 slides · JetBlue
Conference presentation Investor relations 1 hit
09
The chart uses a waterfall bridge structure to explain the change in NAV.Kinnevik | Results Presentation Deck | 12 slides · Kinnevik
Conference presentation Investor relations Beat · KPI OverviewLoop · Cost Of Inaction1 hit
16
Note: All revenue metrics are 2020 pro-forma excluding RecoveriesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · Solution1 hit
20
The chart uses a stacked bar approach to categorize revenue sources (Index Providers, Processors/Servicing, Data Providers).LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · Solution1 hit
02
Mainz Biomed NV | Investor Presentation Deck | 23 slidesMainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
03
This is a standard IPO offering summary slide with placeholders for specific financial data.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
04
The slide uses a two-column layout to present six key investment pillars.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
06
Mainz Biomed NV | Investor Presentation Deck | 23 slidesMainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · Agitate1 hit
09
The slide uses a combination of bulleted arguments and a process-oriented visual flow to justify the economic value proposition.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The slide uses a bulleted list to detail the partnership strategy, focusing on leveraging existing lab infrastructure to minimize marketing overhead.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
13
Includes a stock market snapshot of Exact Sciences and a clinical performance comparison table.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
14
Includes a disclaimer at the bottom and a product visualization.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
15
Includes a photo of the office building and a grid of partner/affiliate logos.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
17
Mainz Biomed NV | Investor Presentation Deck | 23 slidesMainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
20
The slide serves as a repository for additional information, specifically partner logos and team representation.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
21
Includes a disclaimer at the bottom and a citation for the 85% detection rate.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
22
Mainz Biomed NV | Investor Presentation Deck | 23 slidesMainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
02
Nuvalent | IPO Presentation Deck | 40 slidesNuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
11
The slide uses a three-part process flow to explain the biological mechanism of ROS1-driven disease and resistance.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
13
The table uses a green/white color coding to highlight the competitive advantage of NVL-520.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Beat · Market Sizing1 hit
20
The slide highlights CNS activity via brain penetration, a key component of the NVL-520 target product profile.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
23
The slide uses a hybrid layout combining a staircase diagram for Phase 1 and a structured table for Phase 2.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
27
The table uses a green/white color coding to highlight the superior profile of NVL-655 compared to existing therapies.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
33
Includes disclaimer regarding clinical studies and FDA feedback.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit